Nanomedicine | AIS | Virginia Tech

§ December 24th, 2019 § Filed under Nano Medicine Comments Off on Nanomedicine | AIS | Virginia Tech

Nanomedicineseeks to develop therapeutics to maintain and improve human health by destroying infective agents and malignant cells while enhancing the ability to detect and identify diseases at a much earlier stage than is currently possible. Today, research in nanomedicine has also led the development of implantablenanodevices forin situmonitoring of medical conditions post-surgery and for the alleviation of pain.Nanomedine is no longer a promise - it is a reality and it is here to stay.

The global nanomedicine market was estimated at $139 billion in 2016, a number that reflects the impact of nanotechnological advances in medicine and that is expected to grow with the advent of its use in prevention and intervention of chronic and acute disorders. This is particularly relevant to areas of cancer where targeted delivery by means of nanoparticles and nanoscale systems are among the most promising developments and the area of cardiology where rapid progress arises from the use of nanovectors, nanostructure-based stents, and nanotube scaffolds for tissue regeneration.

Virginia Tech has the only undergraduate Nanomedicine major in the United States. Students in our major will be part of an interdisciplinary programrooted in hands-on laboratory research experience in a collaborative and creative setting with access to state-of-the-art facilitiesand research and educational resources.Nanomedicinestudents will be well-prepared for professional and graduate school as well as exciting careers in health professions, pharmaceuticals, diagnostics and imaging, medical devices and products, and many related areas.

We recommend students in Nanomedicine consider applying to the Integrated Science Curriculum.

Originally posted here:
Nanomedicine | AIS | Virginia Tech

Comments are closed.